OIG: High-price drugs driving up cost of Medicare Part D catastrophic coverage

AHA News Now

Federal payments for Part D catastrophic coverage exceeded $33 billion in 2015, more than triple the amount paid in 2010, according to a new report by the Department of Health and Human Services’ Office of Inspector General. Drugs with an average price of more than $1,000 per month accounted for almost... read more

Topic: Advocacy and Public Policy
Tags: Medicare, drug prices

HRSA issues final rule on 340B drug ceiling prices, manufacturer penalties

AHA News Now

The Health Resources and Services Administration today released a final rule on drug ceiling prices and civil monetary penalties for manufacturers in the 340B Drug Pricing Program. Required by the Affordable Care Act, the rule amends Section 340B of the Public Health Service Act to impose monetary... read more

Topic: Advocacy and Public Policy
Tags: 340B, regulation, drug prices

HHS report to Congress shows increase in prescription drug spending

AHA News Now

Growth in prescription drug spending has accelerated considerably in recent years, and it is projected to continue rising during the next decade, according to a report the Department of Health and Human Services recently submitted to Congress. Specifically, the report shows that growth in retail... read more

Topic: Advocacy and Public Policy
Tag: drug prices

CMS: National health spending grows 5.8% in 2015

AHA News Now

U.S. spending on health care grew 5.8% in 2015, primarily due to increased use and intensity of services as millions gained health coverage, as well as continued significant growth in spending for retail prescription drugs, the Centers for Medicare & Medicaid Services reported today in Health Affairs.... read more

Topic: Advocacy and Public Policy
Tags: physicians, Medicare, Coverage, Medicaid, drug prices

CMS releases 2015 data on Medicare, Medicaid drug spending

AHA News Now

Forty drugs accounted for 69% of Medicare spending for drugs administered in physician and hospital outpatient settings last year, according to an updated dashboard released today by the Centers for Medicare & Medicaid Services. Six of the drugs accounted for more than $1 billion each in Part B spending,... read more

Topic: Advocacy and Public Policy
Tags: Medicare, Medicaid, drug prices

State leaders propose solutions to rising prescription drug costs

AHA News Now

The National Academy for State Health Policy today issued 11 proposals to help states rein in rising prescription drug costs. Developed by a panel of state leaders, the policy options include: increasing price transparency; creating a public utility model to oversee drug prices; bulk purchasing critical... read more

Topic: Advocacy and Public Policy
Tag: drug prices

High Drug Prices Hurt Everyone

Blog

More evidence this week of how unchecked drug price increases are forcing hospitals to make tough choices and are a serious economic threat to the patients and communities we serve. An AHA/Federation of American Hospitals-commissioned report by the University of Chicago’s NORC showed inpatient hospital... read more

Topic: Advocacy and Public Policy
Tag: drug prices

AHA, FAH report documents dramatic rise in inpatient drug costs

AHA News

Inpatient hospital drug costs increased more than 38% per admission between 2013 and 2015, according to a report from the University of Chicago’s NORC, an independent research institution. The report was commissioned by the AHA and Federation of American Hospitals (FAH), who unveiled its findings at an... read more

Topic: Advocacy and Public Policy
Tag: drug prices

AHA, FAH report documents dramatic rise in inpatient drug costs

AHA News Now

Inpatient hospital drug costs increased more than 38% per admission between 2013 and 2015, according to a new report from the University of Chicago’s NORC, an independent research institution. According to the analysis of inpatient drug pricing data from 712 community hospitals and two group purchasing... read more

Topic: Advocacy and Public Policy
Tag: drug prices

AHA, AHIP CEOs promote strong and stable exchanges

AHA News Now

AHA President and CEO Rick Pollack and America’s Health Insurance Plans President and CEO Marilyn Tavenner today called for “value-based solutions” that promote strong, stable and affordable health insurance coverage through the insurance exchanges. In an op-ed piece in The Hill, a Capitol Hill newspaper,... read more

Topic: Advocacy and Public Policy
Tags: Coverage, drug prices

Keyword Search

Date